Effects of treatment with DNA-directed cancer chemotherapeutic agents after polyamine depletion.
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D002453:Cell Cycle / Q000187:drug effects; D004273:DNA, Neoplasm / Q000187:drug effects; D004347:Drug Interactions; D000518:Eflornithine / Q000494:pharmacology*; D006801:Humans; D008935:Mitoguazone / Q000494:pharmacology*; D009374:Neoplasms, Experimental / Q000188:drug therapy*; D011073:Polyamines / Q000378:metabolism; D012854:Sister Chromatid Exchange / Q000187:drug effects
D000970:Antineoplastic Agents; D004273:DNA, Neoplasm; D011073:Polyamines; D008935:Mitoguazone; D000518:Eflornithine